Clinical Trial Detail

NCT ID NCT01772797
Title Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Ceritinib

Luminespib

Age Groups: adult

Additional content available in CKB BOOST